Every round on record, with the sources behind each and the investors on them.
A genomic medicine developer
whitelabgx.comLinkedInParis, FranceBiotechYC W22Founded 201954 people
3 sources · checked 1 time, last 27m ago
The company release dates the announcement October 6; Axios published its report October 5, so the company's release controls.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series B | $26M $37M to date | 2026-10-05 | AVP | 1 outlet. #37 in Trending |
3 sources · checked 1 time, last 27m ago [ VERIFIED · CORRECTED ] read against 3 sources
The company release dates the announcement October 6; Axios published its report October 5, so the company's release controls. | ||||
WhiteLab Genomics uses AI and computational biology to design and optimize the delivery vehicles and genetic payloads that pharmaceutical and biotechnology partners need to develop genomic medicines.
LinkedIn via Alexandria from ycombinator.com
Checked against 12 sources today
Via Alexandria from FullEnrich: type, industry
Also named as backers in company research: Y Combinator